Jh. Ireland et al., Reactivity of 13 in vitro expressed hepatitis B surface antigen variants in 7 commercial diagnostic assays, HEPATOLOGY, 31(5), 2000, pp. 1176-1182
The primary marker of current hepatitis B infection is the surface antigen
(HBsAg), however HBsAg negativity does not exclude hepatitis B viremia, HBs
Ag variants can be responsible for such diagnostic failures. Here 13 differ
ent HBsAg variants were cloned, variant protein produced in a mammalian exp
ression system, and tested using 7 commercial HBsAg diagnostic assays. Of 1
2 variants analyzed, 6 samples displayed similar reactivity to the positive
control (containing standard HBsAg sequence) in most of the assays, but 6
samples, containing various mutations throughout the entire major hydrophil
ic region (MHR), showed reduced reactivity, It was found that the loss of c
ysteine at amino acid (aa) 124 in 1 sample affected the secretion as well a
s the reactivity of HBsAg in the expression system. Thus, not all assays ar
e equally able to detect HBsAg variants, implying that, to attain an accept
able level of sensitivity, the antibody repertoire of the current assays sh
ould be extended.